
„AstraZeneca“ yra mokslu pagrįsta biofarmacijos bendrovė, kurianti ir komercializuojanti receptinius vaistus svarbiausioms sveikatos problemoms spręsti. Jos veikla apima onkologiją, širdies ir kraujagyslių, inkstų bei medžiagų apykaitos ligas ir kvėpavimo takų ligas, derinant farmacijos tyrimus, vaistų kūrimą ir pasaulinį tiekimą. Daugiau nei 100 šalių veikianti „AstraZeneca“ suburia komandas, siekiančias tobulinti gydymo būdus ir gerinti pacientų gydymo rezultatus visame pasaulyje.
Associate Director, Translational Medicine Lead – B-Cell Oncology
Lead biomarker strategy for AstraZeneca’s B-cell cancer programs, guiding patient selection, dose decisions, resistance research, and clinical translation.
Aprašymas
- Set translational strategies for B-cell cancer programs from preclinical research through Phase 1/2 and, when needed, Phase 3.
- Use human genetics, expression, and clinical evidence to define indications, stratify patients, and refine target populations.
- Design and interpret target-engagement and pharmacodynamic biomarker measures to support dose selection and proof of mechanism.
- Study resistance mechanisms using longitudinal and relapse samples.
- Assess B-cell tumor biology, pathway interactions, and the tumor microenvironment to inform combination strategies.
- Oversee development, validation, and use of fit-for-purpose assays with internal teams and external laboratories or CROs.
- Integrate biomarker strategies and endpoints into study protocols, sample manuals, and statistical plans.
- Coordinate with biosample and precision diagnostics teams on sample collection, traceability, and companion diagnostic alignment.
- Represent Translational Medicine on cross-functional teams and connect findings across the B-cell portfolio.
- Prepare governance materials, study reports, Go/No-Go recommendations, health authority interactions, and regulatory filings.
- Present scientific findings to internal audiences and external forums.
Reikalavimai
- PhD in a relevant biological science, such as hematology-oncology, immunology, oncology, molecular biology, or a related field.
- Postdoctoral and/or industry experience.
- 0–3+ years of experience with T-cell-engaging bispecifics in oncology or hematology drug development.
- Demonstrated experience with antibody-drug conjugates in hematology or oncology development.
- Experience contributing to early-phase oncology trials, including biomarker planning, protocol input, and sample analysis.
- Expertise in biomarker methods such as flow cytometry, immunohistochemistry, molecular profiling, NGS, ctDNA, MRD assessment, cytokine and immune profiling, and other omics approaches.
- Knowledge of B-cell malignancies, including B-ALL, B-CLL, and NHL, covering disease biology, standard treatments, and therapeutic resistance.
- In-depth understanding of immunology and the tumor microenvironment in B-cell cancers.
- Understanding of clinical development from dose escalation through registration.
- Ability to independently deliver translational programs with regular managerial support.
- Ability to work effectively and provide scientific leadership on cross-functional teams in a matrixed pharmaceutical or biotechnology setting.
- Ability to synthesize scientific data and explain implications for Go/No-Go decisions.
- Excellent communication and presentation skills.
- Desired: experience with small-molecule hematology treatments, cell therapy programs, MRD methods, multi-omic biomarker data, regulatory expectations for biomarker validation or companion diagnostic development, and mentoring junior scientists.
Privalumai
- Short-term incentive bonuses
- Equity awards for salaried roles
- Qualified retirement plans
- Paid leave, including vacation, holidays, and other leaves
- Health coverage
- Dental coverage
- Vision coverage
- Flexible work arrangements, with expected office attendance
- Accommodation for disabilities or special needs
Susiję darbai
Darbo pasiūlymų nerasta
Pabandykite pakeisti arba išvalyti filtrus, kad rastumėte daugiau galimybių.